×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ATRC – atricure, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ATRC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/5
01:06 am
atrc
AtriCure (ATRC) was upgraded by Wall Street Zen from "buy" to "strong
Low
Report
AtriCure (ATRC) was upgraded by Wall Street Zen from "buy" to "strong
4/3
06:54 am
atrc
AtriCure (ATRC) was upgraded by Freedom Capital to "strong-buy".
Low
Report
AtriCure (ATRC) was upgraded by Freedom Capital to "strong-buy".
3/18
04:35 pm
atrc
AtriCure CSO Sells 5,000 Shares — A Modest Trim or a Pattern Worth Watching? [Yahoo! Finance]
Low
Report
AtriCure CSO Sells 5,000 Shares — A Modest Trim or a Pattern Worth Watching? [Yahoo! Finance]
3/11
05:56 am
atrc
AtriCure CFO Sees 12%-14% Organic Growth in 2026 as Pain Management Adoption Accelerates [Yahoo! Finance]
Medium
Report
AtriCure CFO Sees 12%-14% Organic Growth in 2026 as Pain Management Adoption Accelerates [Yahoo! Finance]
2/24
08:14 am
atrc
AtriCure to Participate in the Citizens Life Sciences Conference [Yahoo! Finance]
Low
Report
AtriCure to Participate in the Citizens Life Sciences Conference [Yahoo! Finance]
2/24
08:00 am
atrc
AtriCure to Participate in the Citizens Life Sciences Conference
Low
Report
AtriCure to Participate in the Citizens Life Sciences Conference
2/20
07:27 am
atrc
AtriCure (NASDAQ:ATRC) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Low
Report
AtriCure (NASDAQ:ATRC) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
2/18
10:10 am
atrc
AtriCure (NASDAQ:ATRC) was given a new $53.00 price target on by analysts at Canaccord Genuity Group Inc..
Low
Report
AtriCure (NASDAQ:ATRC) was given a new $53.00 price target on by analysts at Canaccord Genuity Group Inc..
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
2/18
07:01 am
Downgrades
Outperform
Market Perform
Oppenheimer Holdings, Inc.
Medium
Report
-9.4%
Date
Time
Symbol
Headline
Impact
4/6
11:55 am
atrc
Form DEF 14A AtriCure, Inc. For: Apr 06
Low
Report
Form DEF 14A AtriCure, Inc. For: Apr 06
3/26
04:11 pm
atrc
Form SCHEDULE 13G/A AtriCure, Inc. Filed by: VANGUARD GROUP INC
Medium
Report
Form SCHEDULE 13G/A AtriCure, Inc. Filed by: VANGUARD GROUP INC
3/16
08:15 am
atrc
Form 4 AtriCure, Inc. For: Mar 12 Filed by: Doraiswamy Vinayak
Low
Report
Form 4 AtriCure, Inc. For: Mar 12 Filed by: Doraiswamy Vinayak
3/12
04:38 pm
atrc
Form 144 AtriCure, Inc. Filed by: Doraiswamy Vinayak
Low
Report
Form 144 AtriCure, Inc. Filed by: Doraiswamy Vinayak
3/12
08:53 am
atrc
Form 4 AtriCure, Inc. For: Mar 10 Filed by: WHITE ROBERT S.
Low
Report
Form 4 AtriCure, Inc. For: Mar 10 Filed by: WHITE ROBERT S.
3/9
08:33 am
atrc
Form 4 AtriCure, Inc. For: Mar 06 Filed by: CARREL MICHAEL H
Low
Report
Form 4 AtriCure, Inc. For: Mar 06 Filed by: CARREL MICHAEL H
3/3
04:54 pm
atrc
Form 4 AtriCure, Inc. For: Mar 01 Filed by: CARREL MICHAEL H
Low
Report
Form 4 AtriCure, Inc. For: Mar 01 Filed by: CARREL MICHAEL H
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
4/8
Form DEF 14A AtriCure, Inc. For: Apr 08
14.3%
4/7 AtriCure Inc. (NASDAQ: ATRC) is now covered by analysts at Oppenheimer Holdings Inc.. They set a "buy" rating and a $45.00 price target on the stock. 7.5%
4/29 Form 4 AtriCure, Inc. For: Apr 27 Filed by: Lanning Mark R 5.1%
4/9 AtriCure pulls FY 2020 guidance amid COVID-19 [Seeking Alpha] 4.5%
12/5 Form 4 AtriCure, Inc. For: Dec 04 Filed by: Florin Daniel P 4.5%
4/30 AtriCure, Inc. (ATRC) CEO Michael Carrel on Q1 2020 Results - Earnings Call Transcript [Seeking Alpha] 4.3%
1/17 Form 4 AtriCure, Inc. For: Jan 15 Filed by: Collar Mark A 4.1%
1/16 Form 4 AtriCure, Inc. For: Jan 14 Filed by: CARREL MICHAEL H 4.1%
1/27 Form SC 13G/A AtriCure, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP 3.2%
4/10 Form SC 13G/A AtriCure, Inc. Filed by: FMR LLC 3.0%
4/7 AtriCure Inc. (NASDAQ: ATRC) is now covered by analysts at Oppenheimer Holdings Inc.. They set a "buy" rating and a $45.00 price target on the stock. 7.5%
4/29 Form 4 AtriCure, Inc. For: Apr 27 Filed by: Lanning Mark R 5.1%
4/9 AtriCure pulls FY 2020 guidance amid COVID-19 [Seeking Alpha] 4.5%
12/5 Form 4 AtriCure, Inc. For: Dec 04 Filed by: Florin Daniel P 4.5%
4/30 AtriCure, Inc. (ATRC) CEO Michael Carrel on Q1 2020 Results - Earnings Call Transcript [Seeking Alpha] 4.3%
1/17 Form 4 AtriCure, Inc. For: Jan 15 Filed by: Collar Mark A 4.1%
1/16 Form 4 AtriCure, Inc. For: Jan 14 Filed by: CARREL MICHAEL H 4.1%
1/27 Form SC 13G/A AtriCure, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP 3.2%
4/10 Form SC 13G/A AtriCure, Inc. Filed by: FMR LLC 3.0%
TOP News Decliners
3/14
AtriCure Inc. (NASDAQ: ATRC) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating.
-17.0%
8/13 AtriCure Inc. (NASDAQ: ATRC) was downgraded by analysts at Northland Securities from an "outperform" rating to a "market perform" rating. -5.2%
8/2 Form 4 AtriCure, Inc. For: Jul 31 Filed by: CARREL MICHAEL H -4.3%
8/13 AtriCure To Acquire SentreHEART For Atrial Fib Tech [Seeking Alpha] -4.2%
2/21 AtriCure Inc. (NASDAQ: ATRC) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. -3.7%
4/1 AtriCure Inc. (NASDAQ: ATRC) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -3.6%
1/31 Form 4 AtriCure, Inc. For: Jan 29 Filed by: Seith Douglas J -3.6%
2/19 AtriCure Inc. (NASDAQ: ATRC) had its price target raised by analysts at Piper Sandler from to . -3.5%
6/25 AtriCure Inc. (NASDAQ: ATRC) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $35.00 price target on the stock. -3.4%
4/15 AtriCure to Announce First Quarter 2020 Financial Results -3.4%
8/13 AtriCure Inc. (NASDAQ: ATRC) was downgraded by analysts at Northland Securities from an "outperform" rating to a "market perform" rating. -5.2%
8/2 Form 4 AtriCure, Inc. For: Jul 31 Filed by: CARREL MICHAEL H -4.3%
8/13 AtriCure To Acquire SentreHEART For Atrial Fib Tech [Seeking Alpha] -4.2%
2/21 AtriCure Inc. (NASDAQ: ATRC) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. -3.7%
4/1 AtriCure Inc. (NASDAQ: ATRC) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -3.6%
1/31 Form 4 AtriCure, Inc. For: Jan 29 Filed by: Seith Douglas J -3.6%
2/19 AtriCure Inc. (NASDAQ: ATRC) had its price target raised by analysts at Piper Sandler from to . -3.5%
6/25 AtriCure Inc. (NASDAQ: ATRC) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $35.00 price target on the stock. -3.4%
4/15 AtriCure to Announce First Quarter 2020 Financial Results -3.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: